Kristie Bloom
Overview
Explore the profile of Kristie Bloom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
479
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Bloom K, Ely A, Maepa M, Arbuthnot P
Gene Ther
. 2024 Nov;
32(1):4-7.
PMID: 39558149
No abstract available.
3.
4.
Galy A, Berkhout B, Breckpot K, Pichon C, Bloom K, Kiem H, et al.
Hum Gene Ther
. 2023 Aug;
34(17-18):896-904.
PMID: 37639360
The development of prophylatic or therapeutic medicines for infectious diseases is one of the priorities for health organizations worldwide. Innovative solutions are required to achieve effective, safe, and accessible treatments...
5.
Kairuz D, Samudh N, Ely A, Arbuthnot P, Bloom K
Pharmaceutics
. 2023 Apr;
15(4).
PMID: 37111658
Africa bears the highest burden of infectious diseases, yet the continent is heavily reliant on First World countries for the development and supply of life-saving vaccines. The COVID-19 pandemic was...
6.
Kairuz D, Samudh N, Ely A, Arbuthnot P, Bloom K
Front Immunol
. 2022 Nov;
13:1018961.
PMID: 36353641
Synthetic mRNA technologies represent a versatile platform that can be used to develop advanced drug products. The remarkable speed with which vaccine development programs designed and manufactured safe and effective...
7.
Maepa M, Ely A, Kramvis A, Bloom K, Naidoo K, Simani O, et al.
Viruses
. 2022 Sep;
14(9).
PMID: 36146747
Despite being vaccine-preventable, hepatitis B virus (HBV) infection remains the seventh leading cause of mortality in the world. In South Africa (SA), over 1.9 million people are chronically infected with...
8.
Samudh N, Shrilall C, Arbuthnot P, Bloom K, Ely A
Front Immunol
. 2022 Feb;
13:834650.
PMID: 35154157
Infection with the hepatitis B virus (HBV) continues to pose a major threat to public health as approximately 292 million people worldwide are currently living with the chronic form of...
9.
Smith T, Singh P, Chmielewski K, Bloom K, Cathomen T, Arbuthnot P, et al.
Viruses
. 2021 Aug;
13(7).
PMID: 34372550
Persistent hepatitis B virus (HBV) infection remains a serious medical problem worldwide, with an estimated global burden of 257 million carriers. Prophylactic and therapeutic interventions, in the form of a...
10.
Singh P, Kairuz D, Arbuthnot P, Bloom K
World J Gastroenterol
. 2021 Jun;
27(23):3182-3207.
PMID: 34163105
Global prophylactic vaccination programmes have helped to curb new hepatitis B virus (HBV) infections. However, it is estimated that nearly 300 million people are chronically infected and have a high...